Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Kiniksa Pharmaceuticals Ltd
Today
Create an eToro account to buy KNSA stock on a secure, user-friendly, multi-asset trading platform.
Buy Kiniksa Pharmaceuticals Ltd
Buy Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd KNSA
Stocks-KNSA-Kiniksa Pharmaceuticals Ltd

Kiniksa Pharmaceuticals Ltd KNSA

$20.020.33(1.68%)(1D)

KNSA Stock Price Chart

‎6.89‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Kiniksa Pharmaceuticals Ltd share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Kiniksa Pharmaceuticals Ltd share price today is $20.02, reflecting a ‎1.68‎% change over the last 24 hours and ‎1.52‎% over the past week. The current market capitalization of KNSA is 1.45B with an average volume in the last three months of 455274.88. The stock has a P/E ratio of -147.97 and a dividend yield of 0%. With the stock’s beta sitting at 0.93
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$1.45B

Day’s Range
i
Shows the high and low prices of the day.
18.08 - 20.67

52W Range
i
Shows the high and low prices of the last year.
15.5 - 28.06

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
455274.88

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-147.97

Revenue
i
The total income generated by this company’s goods and services last year.
$384.1M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$20.02

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-0.14

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.93

What Is Kiniksa Pharmaceuticals Ltd?
Kiniksa Pharmaceuticals Ltd - Class A is a biopharmaceutical company focusing on the discovery, development, and commercialisation of therapeutic medicines. Operating globally, it addresses several debilitating diseases with significant unmet medical need.

Operating in the healthcare sector, Kiniksa Pharmaceuticals has a pipeline of clinical-stage, immune-modulating product candidates that target conditions such as recurrent pericarditis and rheumatoid arthritis. Included in its portfolio is the development of treatments and therapies for autoinflammatory, cardiovascular and autoimmune diseases.

Stay up to date on the share price of KNSA by adding it to your eToro watchlist.

How can I buy Kiniksa Pharmaceuticals Ltd stocks?

To purchase Kiniksa Pharmaceuticals Ltd:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Kiniksa Pharmaceuticals Ltd (KNSA) page and place an order to buy Kiniksa Pharmaceuticals Ltd.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy Kiniksa Pharmaceuticals Ltd
Invest in Kiniksa Pharmaceuticals Ltd
Today
Create an eToro account to buy KNSA stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of KNSA is $20.02.
The average price target for Kiniksa Pharmaceuticals Ltd is $20.02. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Kiniksa Pharmaceuticals Ltd based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Kiniksa Pharmaceuticals Ltd is $1.45B
Scroll to top